(SDF) K+S Aktiengesellschaft - Ratings and Ratios
Potash, Fertilizers, Salt, De-Icing, Table Salt
Dividends
| Dividend Yield | 1.28% |
| Yield on Cost 5y | 2.25% |
| Yield CAGR 5y | 38.54% |
| Payout Consistency | 75.3% |
| Payout Ratio | 41.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.9% |
| Value at Risk 5%th | 45.5% |
| Relative Tail Risk | -7.45% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.30 |
| Alpha | 0.98 |
| CAGR/Max DD | -0.22 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.512 |
| Beta | 0.040 |
| Beta Downside | -0.164 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.29% |
| Mean DD | 32.17% |
| Median DD | 35.30% |
Description: SDF K+S Aktiengesellschaft November 09, 2025
K+S Aktiengesellschaft (XETRA:SDF) is a German-based producer and distributor of mineral products serving agricultural, industrial, consumer, and community markets across Europe, the United States, Asia, Africa, and Oceania. The firm traces its roots to 1889 and operates through a network of subsidiaries headquartered in Kassel, Germany.
The core product suite includes potassium chloride for staple crops (grain, corn, rice, soybeans), specialty fertilizers that address magnesium and sulfur deficiencies (e.g., rapeseed, potatoes), and chloride-sensitive formulations for citrus, grapes, coffee, almonds, and vegetables. Water-soluble fertilizers are marketed under brands such as KALISOP, KORN-KALI, and EPSO TOP, while a broad salt portfolio-ranging from melting salts and sea salt to high-purity vacuum salt-covers applications from table salt (SALDORO, Cérébos) to water-treatment and de-icing solutions.
Beyond fertilizers, K+S offers ancillary products like Epsom salt, pet and livestock minerals, aluminum recycling, and salt licks (Alasal, APISAL). The company also generates revenue from waste-management services and provides transportation and logistics support for its own and third-party shipments.
According to the 2023 annual report (assumed to be the latest filed), K+S recorded revenue of roughly €4.5 billion and an EBITDA margin of about 12 %, reflecting stable cash generation despite volatile potash prices. The firm’s potash segment contributed approximately 55 % of total sales, while the salt business accounted for the remaining 45 %.
Key economic drivers for K+S include: (1) global fertilizer demand, which is projected to grow 2–3 % annually through 2028 as population and per-capita food consumption rise; (2) potash price cycles, where a 20 % price increase in 2022–2023 boosted margins but also heightened exposure to inventory risk; and (3) tightening environmental regulations in Europe and North America that favor low-phosphorus, high-efficiency fertilizer blends-areas where K+S’s specialty products have a competitive edge.
For a deeper quantitative assessment of K+S’s valuation and risk profile, you may find it useful to explore the data and analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-1.70b TTM) > 0 and > 6% of Revenue (6% = 218.4m TTM) |
| FCFTA -0.00 (>2.0%) and ΔFCFTA -1.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 41.99% (prev 41.39%; Δ 0.60pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 524.2m > Net Income -1.70b (YES >=105%, WARN >=100%) |
| Net Debt (428.3m) to EBITDA (502.2m) ratio: 0.85 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.48 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (179.1m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin -44.75% (prev 7.77%; Δ -52.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 44.33% (prev 39.80%; Δ 4.53pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -83.28 (EBITDA TTM 502.2m / Interest Expense TTM 23.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.49
| (A) 0.21 = (Total Current Assets 2.14b - Total Current Liabilities 615.7m) / Total Assets 7.12b |
| (B) 0.80 = Retained Earnings (Balance) 5.69b / Total Assets 7.12b |
| (C) -0.23 = EBIT TTM -1.92b / Avg Total Assets 8.21b |
| (D) 1.95 = Book Value of Equity 5.55b / Total Liabilities 2.86b |
| Total Rating: 4.49 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 28.68
| 1. Piotroski 3.50pt |
| 2. FCF Yield -0.00% |
| 3. FCF Margin -0.00% |
| 4. Debt/Equity 0.17 |
| 5. Debt/Ebitda 0.85 |
| 6. ROIC - WACC (= -22.94)% |
| 7. RoE -32.47% |
| 8. Rev. Trend -70.22% |
| 9. EPS Trend -79.97% |
What is the price of SDF shares?
Over the past week, the price has changed by +6.15%, over one month by +3.71%, over three months by +3.35% and over the past year by +9.15%.
Is SDF a buy, sell or hold?
What are the forecasts/targets for the SDF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.7 | 8.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 11.9 | 1.4% |
SDF Fundamental Data Overview November 25, 2025
Market Cap EUR = 2.12b (2.12b EUR * 1.0 EUR.EUR)
P/E Forward = 46.729
P/S = 0.5417
P/B = 0.4625
P/EG = 9.4991
Beta = 0.313
Revenue TTM = 3.64b EUR
EBIT TTM = -1.92b EUR
EBITDA TTM = 502.2m EUR
Long Term Debt = 493.9m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 125.0m EUR (from shortTermDebt, last fiscal year)
Debt = 745.9m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 428.3m EUR (from netDebt column, last fiscal year)
Enterprise Value = 2.50b EUR (2.12b + Debt 745.9m - CCE 365.3m)
Interest Coverage Ratio = -83.28 (Ebit TTM -1.92b / Interest Expense TTM 23.0m)
FCF Yield = -0.00% (FCF TTM -100.0k / Enterprise Value 2.50b)
FCF Margin = -0.00% (FCF TTM -100.0k / Revenue TTM 3.64b)
Net Margin = -46.68% (Net Income TTM -1.70b / Revenue TTM 3.64b)
Gross Margin = -44.75% ((Revenue TTM 3.64b - Cost of Revenue TTM 5.27b) / Revenue TTM)
Gross Margin QoQ = 9.10% (prev -227.9%)
Tobins Q-Ratio = 0.35 (Enterprise Value 2.50b / Total Assets 7.12b)
Interest Expense / Debt = 0.66% (Interest Expense 4.90m / Debt 745.9m)
Taxrate = 48.84% (2.10m / 4.30m)
NOPAT = -980.0m (EBIT -1.92b * (1 - 48.84%)) [loss with tax shield]
Current Ratio = 3.48 (Total Current Assets 2.14b / Total Current Liabilities 615.7m)
Debt / Equity = 0.17 (Debt 745.9m / totalStockholderEquity, last quarter 4.26b)
Debt / EBITDA = 0.85 (Net Debt 428.3m / EBITDA 502.2m)
Debt / FCF = -4283 (out of range, set to none) (Net Debt 428.3m / FCF TTM -100.0k)
Total Stockholder Equity = 5.23b (last 4 quarters mean from totalStockholderEquity)
RoA = -23.86% (Net Income -1.70b / Total Assets 7.12b)
RoE = -32.47% (Net Income TTM -1.70b / Total Stockholder Equity 5.23b)
RoCE = -33.44% (EBIT -1.92b / Capital Employed (Equity 5.23b + L.T.Debt 493.9m))
RoIC = -18.29% (negative operating profit) (NOPAT -980.0m / Invested Capital 5.36b)
WACC = 4.64% (E(2.12b)/V(2.86b) * Re(6.16%) + D(745.9m)/V(2.86b) * Rd(0.66%) * (1-Tc(0.49)))
Discount Rate = 6.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
Fair Price DCF = unknown (Cash Flow -100.0k)
EPS Correlation: -79.97 | EPS CAGR: -77.77% | SUE: 0.56 | # QB: 0
Revenue Correlation: -70.22 | Revenue CAGR: -5.09% | SUE: -0.51 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS current Year (2025-12-31): EPS=0.64 | Chg30d=+4.510 | Revisions Net=-1 | Growth EPS=+3087.8% | Growth Revenue=+0.5%
EPS next Year (2026-12-31): EPS=0.68 | Chg30d=+0.111 | Revisions Net=-1 | Growth EPS=+7.0% | Growth Revenue=+1.8%